Privatlivspræferencer
Inderes bruger cookies for at give en bedre brugeroplevelse og en personlig service. Ved at give samtykke til brugen af cookies kan vi udvikle en endnu bedre service og vil kunne levere indhold, der er interessant for dig.
  • Forum
  • Premium
  • Aktiemarkeder
    • MarkederRealtidskurser, indekser og markedsudvikling
    • BørskalenderKommende resultater, noteringer og virksomhedsbegivenheder
    • UdbyttekalenderKommende og tidligere udbytter
  • Selskaber
    • SelskaberGennemse og filtrer den fulde liste over børsnoterede selskaber
    • OpdagInspiration til din næste investering
    • BørsnoteringerNye noteringer og kommende børsintroduktioner
    • Invitationer til generalforsamlingerDatoer for generalforsamlinger og aktionærinformation
  • Aktieanalyse
    • ResearchEkspertaktieanalyse og anbefalinger
    • ArtiklerNyheder, indsigter og markedskommentarer
    • PorteføljeInderes modelportefølje
  • Lær om investering
    • AnalyseskoleLær at læse og forstå aktieanalyse
    • inderesTVVideocenter for aktieanalyse, forskning og ekspertkommentarer
    • TransskriptionerFuldstændige udskrifter af resultatopkald og investormøder
    • AktieoversigtSammenlign nøgletal og udvikling på tværs af flere aktier
    • Earnings SeasonCompare EPS estimates to reported results
    • InsidertransaktionerFølg købs- og salgsaktivitet fra virksomhedsinsidere
    • ShortsalgSe hvilke børsnoterede selskaber der har offentliggjorte korte positioner
    • Virtuel analytiker-chatStil spørgsmål og få AI-drevne investeringsindsigter med det samme
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer

Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.

Magle Chemoswed Holding AB (publ) initiates a written procedure in order to utilise the option to pay PIK Interest under its super senior secured fixed rate bonds

Magle ChemoswedPressemeddelelse17.11.2026, 13.55

Magle Chemoswed Holding AB (publ) (the "Company") hereby announces that it, through Nordic Trustee & Agency AB (publ) as agent (the “Agent”) under its super senior secured fixed rate bonds with ISIN NO0013758086 (the "Bonds"), has initiated a written procedure (the "Written Procedure") in order to enable Bondholders to vote for or against the Company's request to utilise the PIK Component for the current Interest Period which ends on 1 December 2026 (with Interest Payment Date occurring on 2 December 2026).

Pursuant to the Terms and Conditions of the Bonds, the Company may elect to pay a part of the Interest under the Bonds as PIK Interest, subject to the Company giving prior notice of no less than 10 CSD Business Days' before the first day of the relevant Interest Period. For the current Interest Period the deadline for serving a notice to elect PIK Interest expired before the issuance of the Bonds and it was therefore not technically possible for the Company to elect the option to pay PIK Interest for the current Interest Period. It is against this background that the Company has initiated the Written Procedure.

 

Voting Information
 
To be eligible to participate in the Written Procedure, a person must be a holder of Bonds on 19 November 2026, meaning that the person must be registered on a securities account with Verdipapirsentralen ASA (Euronext Securities Oslo) as a direct registered owner or authorised nominee with respect to one or several Bonds.
 
The Agent must receive the voting form no later than 14:00 CET on 2 December 2026 either by mail, courier or email to the Agent using the contact details set out in Section 4.6 in the notice of the Written Procedure. Votes received thereafter may be disregarded.
 
For further information regarding the Written Procedure and the requests, including the full details of the proposal, please refer to the notice of Written Procedure available on the Company's website (https://maglegroup.com/) and via the Agent's information service Stamdata (https://stamdata.com/).

Contacts


Aaron Wong, CEO, phone +46 (0)76 664 35 79, aaron.wong@maglegroup.com

About Us


The Magle Group aims to establish itself as a leader in high-quality life-changing healthcare innovations to meet medical needs through scientific excellence. Today, the Group includes two operational areas. Magle Chemoswed – a contract manufacturing organization (CMO) with a strong reputation for its high-quality development and manufacturing expertise and Magle Biopolymers A/S - a specialized manufacturing organization of Dextran technology. Learn more on www.maglechemoswed.com and www.maglegroup.com and www.maglebiopolymers.com

Attachments


Magle Chemoswed Holding AB (publ) initiates a written procedure in order to utilise the option to pay PIK Interest under its super senior secured fixed rate bonds